The cytoskeleton as a target in quinone toxicity

The cytoskeleton plays a central role in maintaining cell shape and function. Prior research has shown that disruptions to cytoskeletal integrity can lead to morphological changes like plasma membrane blebbing. However, the mechanisms by which certain quinones induce these changes remain unclear. Established knowledge suggests that sulfhydryl groups and calcium signaling are involved in cytoskeletal regulation. No prior work had resolved whether alkylating or redox cycling quinones act through shared or distinct pathways. This gap motivated further investigation into how quinones affect cytoskeletal structure. Researchers sought to distinguish between alkylation and oxidation as potential mechanisms. The study aimed to clarify whether these processes are interconnected or separate. Understanding these effects could help identify cytoskeletal vulnerabilities in toxicology.

This study aimed to explore how quinones induce structural and biochemical changes in the cytoskeleton. The researchers focused on two types of quinones: alkylating and redox cycling. They wanted to determine whether these quinones share a common mechanism or act through distinct pathways. The primary goal was to identify the role of sulfhydryl groups and calcium signaling in these effects. The study also sought to assess the timing of ATP depletion relative to morphological changes. By comparing the effects of different quinones, the researchers hoped to clarify the underlying mechanisms. They tested whether thiol reductants could prevent these changes. The findings could help distinguish between alkylation and oxidation as causes of cytoskeletal damage.

The researchers exposed mammalian cells to toxic concentrations of quinones and observed plasma membrane blebbing. They analyzed changes in cytoskeletal microfilaments and plasma membrane proteins. Techniques included measuring sulfhydryl group depletion and cytosolic calcium levels. The study compared the effects of alkylating and redox cycling quinones. Thiol reductants like dithiothreitol were used to test their protective effects. ATP levels were monitored to assess their role in membrane blebbing. The timing of ATP depletion relative to morphological changes was tracked. These methods allowed the team to differentiate between alkylation and oxidation pathways.

Exposure to quinones caused plasma membrane blebbing and cytoskeletal changes. Alkylating quinones led to actin cross-linking and alpha-actinin dissociation. Redox cycling quinones also disrupted cytoskeletal organization. Both types of quinones depleted sulfhydryl groups and increased cytosolic calcium. Thiol reductants prevented oxidation effects but not alkylation effects. ATP depletion occurred after blebbing onset but was not causative. The study found distinct mechanisms for alkylating and redox cycling quinones. These findings suggest separate biochemical pathways for cytoskeletal disruption.

The study shows that alkylating and redox cycling quinones cause similar cytoskeletal changes through different mechanisms. Alkylation affects sulfhydryl groups, while oxidation involves redox cycling. Thiol reductants can prevent oxidation effects but not alkylation effects. The increase in cytosolic calcium is linked to both types of quinones. ATP depletion occurs after blebbing but is not the cause. The findings suggest that sulfhydryl group depletion is a key factor in cytoskeletal disruption. The authors propose that these mechanisms are distinct but interconnected. The results highlight the importance of sulfhydryl groups in cytoskeletal stability.